Tumor-Derived Cell Culture Model for the Investigation of Meningioma Biology

Meningioma is the most common primary central nervous system tumor. Although mostly nonmalignant, meningioma can cause serious complications by mass effect and vasogenic edema. While surgery and radiation improve outcomes, not all cases can be treated due to eloquent location. Presently no medical treatment is available to slow meningioma growth owing to incomplete understanding of the underlying pathology, which in turn is due to the lack of high-fidelity tissue culture and animal models. We propose a simple and rapid method for the establishment of meningioma tumor-derived primary cultures. These cells can be maintained in culture for a limited time in serum-free media as spheres and form adherent cultures in the presence of 4% fetal calf serum. Many of the tissue samples show expression of the lineage marker PDG2S, which is typically retained in matched cultured cells, suggesting the presence of cells of arachnoid origin. Furthermore, nonarachnoid cells including vascular endothelial cells are also present in the cultures in addition to arachnoid cells, potentially providing a more accurate tumor cell microenvironment, and thus making the model more relevant for meningioma research and high-throughput drug screening.

Automated summary

Meningioma is the most common primary central nervous system tumor, which can cause serious complications by mass effect and vasogenic edema despite being mostly nonmalignant. Current treatments include surgery and radiation, but not all cases can be treated due to location. The lack of medical treatment to slow meningioma growth is attributed to incomplete understanding of the underlying pathology, resulting from the absence of high-fidelity tissue culture and animal models. The proposed method allows for the establishment of meningioma tumor-derived primary cultures, providing a more accurate tumor cell microenvironment for research and drug screening.